The GOG Foundation
Highly Engaged Employees
Highly Engaged EmployeesNon-Profit & Charitable Organizations · Pennsylvania, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1600 John F Kennedy Blvd Ste 1020, Phila...Phone Number
(215) 854-0770Website
www.gog.orgRevenue
$27.9 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
2
1
1
1
About The GOG Foundation
The GOG Foundation, Inc. (GOG) is a not-for-profit organization with the purpose of promoting excellence in the quality and integrity of clinical and basic scientific research in the field of gynecologic malignancies. The GOG is committed to maintaining the highest standards in clinical trials development, execution, analysis and distribution of results. The GOG is the only group in the United States that focuses its research on women with pelvic malignancies, such as cancer of the ovary, uterus and cervix. The GOG is multi-disciplinary in its approach to clinical trials, and includes gynecologic oncologists, medical oncologists, pathologists, radiation oncologists, nurses, statisticians, basic scientists, quality of life experts, data managers and administrative personnel.Explore more
The GOG Foundation Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is The GOG Foundation your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if The GOG Foundation has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when The GOG Foundation launches new products
The GOG Foundation, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once The GOG Foundation has new funding data
Congratulate Masked Content for being promoted to Masked Content at The GOG Foundation
Click to see if The GOG Foundation had a recent Job posting/layoffs
Check out if The GOG Foundation is spiking on competitors!
Earning: See what the market has to say on The GOG Foundation recently announced quarterly report
Recommended Actions
Find VP level buyers at The GOG Foundation
Find 2 more new buyers
Compare Similar Companies to The GOG Foundation
Compare insights from companies similar to The GOG Foundation, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
The GOG Foundation is experiencing very low activity levels compared to other companies in the Organizations sector.
What does this means?
The GOG Foundation is drawing exceptional interest within the Organizations industry, suggesting notable developments or strong market momentum, learn more about The GOG Foundation.
The GOG Foundation Tech Stack
A closer look at the technologies used by The GOG Foundation
See more technologies
Most Recent Scoops
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
The GOG Foundation News & Media
Nykode Therapeutics Initiates Phase 2 Trial of VB10.16 in Second Line HPV16-Positive Cervical Cancer
OSLO, Norway, April 19, 2024 (GLOBE NEWSWIRE) -- Nykode Therapeutics ASA (OSE: NYKD), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies, today announced the initiation of the Phase 2 clinical trial VB-C-04. The trial evaluates VB10.16, the company’s off-the-shelf therapeutic cancer vaccine candidate for HPV16-positive cancers, alone or in combination with Roche’s checkpoint inhibitor atezolizumab (Tecentriq®1) in patients with HPV16-poVerastem Oncology Announces Initiation of a Confirmatory Phase 3 Trial of Avutometinib and Defactinib in Recurrent Low-Grade Serous Ovarian Cancer
BOSTON--(BUSINESS WIRE)--Verastem Oncology (Nasdaq: VSTM) (the “Company”), a biopharmaceutical company committed to advancing new medicines for patients with cancer, announced today that it has initiated its international confirmatory Phase 3 RAMP 301 trial (GOG-3097; ENGOT-ov81/NCRI), evaluating the combination of avutometinib and defactinib versus standard chemotherapy or hormonal therapy for the treatment of recurrent low-grade serous ovarian cancer (LGSOC). “Patients and treating physiciansNovocure Provides Update on Phase 3 ENGOT-ov50 / GOG-3029 / INNOVATE-3 Trial Evaluating Tumor Treating Fields Therapy in Platinum-resistant Ovarian Cancer
ROOT, Switzerland--(BUSINESS WIRE)---- $NVCR--Novocure today announced that the phase 3 INNOVATE-3 clinical trial in platinum-resistant ovarian cancer did not meet its primary endpoint.Verastem Oncology Announces Design for Confirmatory Trial of Avutometinib and Defactinib in Recurrent Low-Grade Serous Ovarian Cancer
BOSTON--(BUSINESS WIRE)--Verastem Oncology (Nasdaq: VSTM) (the “Company”), a biopharmaceutical company committed to advancing new medicines for patients with cancer, announced today that it has finalized with the U.S. Food and Drug Administration (FDA) the design of its confirmatory Phase 3 trial to evaluate the combination of avutometinib and defactinib for the treatment of recurrent low-grade serous ovarian cancer (LGSOC). RAMP 301, a randomized global confirmatory trial, will evaluate the ef
Read more news
Top Non-Profit & Charitable Organizations Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding The GOG Foundation
Sign Up For FreeTo access detailed company insights
The GOG Foundation, Inc. (GOG) is a not-for-profit organization with the purpose of promoting excellence in the quality and integrity of clinical and basic scientific research in the field of gynecologic malignancies. The GOG is committed to maintaining the highest standards in clinical trials development, execution, analysis and distribution of re... Read More
